Kohn, M., Delord, M., Chbat, M., Guemriche, A., Merabet, F., Roupie, A.-L., Lombion, N., Farhat, H., Longval, T., Cabannes-Hamy, A., Lambert, J., Marque-Juillet, S., Raggueneau, V., Osman, J., Spentchian, M., Rigaudeau, S., Rousselot, P. and Besson, C. (2022) “A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia”, Haematologica. Pavia, Italy, 107(6), pp. 1454-1459. doi: 10.3324/haematol.2021.280026.